Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD
NCT01177644 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2012-08-22
Summary
This study will evaluate the safety and preliminary effectiveness of PDS 1.0 in patients with neovascular AMD.
Conditions
- Age-Related Macular Degeneration
Interventions
- DRUG
-
PDS 1.0
Sponsors & Collaborators
-
Forsight Vision4
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-07-31
Countries
- Israel
Study Locations
More Related Trials
-
Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration
NCT05953012 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
NCT00150202 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD
NCT02461771 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)
NCT05562947 ·Status: RECRUITING ·Phase: PHASE3
-
Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration
NCT01570790 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
NCT01024998 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD
NCT01013376 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration
NCT03777254 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration
NCT00239928 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration
NCT01367444 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
NCT05803785 ·Status: RECRUITING ·Phase: PHASE1
-
Intravitreal Faricimab in Patients With Refractory Macular Edema
NCT07093385 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease
NCT05986786 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration
NCT00712491 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).
NCT01624636 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
NCT01535950 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
NCT01255462 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
NCT07275840 ·Status: RECRUITING ·Phase: PHASE2
-
A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration
NCT07024732 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration
NCT02873351 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration
NCT00569140 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
NCT00090532 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
NCT03869684 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
NCT06223048 ·Status: RECRUITING ·Phase: PHASE2
-
A Single-Center Pilot Study to Assess Macular Function
NCT01204541 ·Status: COMPLETED